VNUS® Medical Technologies, Inc.'s ClosureFAST™ RF Catheter Received USFDA 510(k) (Marketing) Clearance

Filed in archive Diagnostics , Treatment on August 7, 2006

A leading provider of Medical devices for the minimally invasive treatment of peripheral vascular disease, VNUS® Medical Technologies, Inc. (Nasdaq: VNUS), has recently received 510(k) clearance from the USFDA to market its ClosureFAST™ radiofrequency catheter in the United States.

VNUS® Medical Technologies, Inc.'s ClosureFAST™ radiofrequency catheter is designed to heat, shrink and occlude refluxing saphenous veins with RF ablation times of just three to five minutes while maintaining the predictably fast and mild patient recovery that physicians have come to expect from RF.

According to VNUS President and Chief Executive Officer, Brian E. Farley:

"Achievement of U.S. marketing clearance is one of several significant milestones we are pursuing for our new ClosureFAST catheter. We are rapidly accumulating clinical experience prior to product launch.

To date, the feedback we have received by users of this catheter and by patients who have received a ClosureFAST procedure has been very positive. The preliminary clinical experience produced with the ClosureFAST catheter has been excellent as evidenced by 100% acute success at closing veins with over 70 veins treated.

This product is expected to be launched by VNUS in the United States in the first quarter of 2007.

Read more at VNUS Medical Technologies, Inc.